Technical Analysis for ENSC - Ensysce Biosciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 0.65 | 12.85% | 0.07 |
ENSC closed up 12.85 percent on Friday, November 1, 2024, on 4.56 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: Nov 7
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
| Crossed Above 200 DMA | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Parabolic Rise | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% |
| Alert | Time |
|---|---|
| 200 DMA Support | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| Rose Above Upper Bollinger Band | 1 day ago |
| Rose Above 200 DMA | 1 day ago |
| 2x Volume Pace | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. Leveraging its Trypsin Activated Abuse Protection (TAAP™) and Multi-Pill Abuse Resistance (MPAR™) platforms, the Company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce’s products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing the human and economic cost. The platforms are covered by an extensive worldwide intellectual property portfolio for a wide array of prescription drug compositions.
Sector: Industrials
Industry: Conglomerates
Keywords: Pain Health Sciences Pharmacy Psychoactive Drugs Opioids Heroin Morphine Opioid Use Disorder Drug Culture
Classification
Sector: Industrials
Industry: Conglomerates
Keywords: Pain Health Sciences Pharmacy Psychoactive Drugs Opioids Heroin Morphine Opioid Use Disorder Drug Culture
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.06 |
| 52 Week Low | 0.1412 |
| Average Volume | 31,353,719 |
| 200-Day Moving Average | 0.61 |
| 50-Day Moving Average | 0.33 |
| 20-Day Moving Average | 0.31 |
| 10-Day Moving Average | 0.44 |
| Average True Range | 0.12 |
| RSI (14) | 68.25 |
| ADX | 43.68 |
| +DI | 59.37 |
| -DI | 8.81 |
| Chandelier Exit (Long, 3 ATRs) | 0.52 |
| Chandelier Exit (Short, 3 ATRs) | 0.49 |
| Upper Bollinger Bands | 0.64 |
| Lower Bollinger Band | -0.02 |
| Percent B (%b) | 1.01 |
| BandWidth | 211.46 |
| MACD Line | 0.07 |
| MACD Signal Line | 0.03 |
| MACD Histogram | 0.0469 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.08 | ||||
| Resistance 3 (R3) | 1.11 | 0.99 | 1.01 | ||
| Resistance 2 (R2) | 0.99 | 0.88 | 0.98 | 0.99 | |
| Resistance 1 (R1) | 0.82 | 0.81 | 0.90 | 0.79 | 0.96 |
| Pivot Point | 0.70 | 0.70 | 0.74 | 0.69 | 0.70 |
| Support 1 (S1) | 0.53 | 0.59 | 0.62 | 0.51 | 0.34 |
| Support 2 (S2) | 0.41 | 0.52 | 0.40 | 0.31 | |
| Support 3 (S3) | 0.24 | 0.41 | 0.29 | ||
| Support 4 (S4) | 0.22 |
